Correspondence 0001493152-24-033199 from Bioquest Corp (BQST) (CIK 0001568628) (BQST)
Bioquest Corp (BQST) (CIK 0001568628)
Date: Aug. 19, 2024 · CIK: 0001568628 · Accession: 0001493152-24-033199
AI Filing Summary & Sentiment
File numbers found in text: 024-12436
Letter
Division of Corporation Finance Office of Life Sciences Offering Statement on Form 1-A, as amended Initially Filed May 15, 2024 File No. 024-12436
Re: Bioquest Corp.
Dear Ms. Hamill:
This letter sets forth the request of BioQuest Corp., (“BQST” or the “Company”) for Qualification of its Regulation A Offering on Form 1-A, as amended.
Kindly be advised that BioQuest Corp. (the “Company”) requests that its Regulation A Offering, as amended, be qualified on Wednesday, August 21, 2024 at 3pm (est) or as soon as practical thereafter. The Company confirms that the State of Georgia is prepared to qualify the Offering.
In connection with the foregoing request, the Company hereby confirms and acknowledges that:
1. should the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission from taking any action with respect to the filing;
2. the action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3. the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We trust the foregoing is in order.
If you have any questions or require any additional information with respect to the above, please do not hesitate to contact me at (714) 978-4425. Thank you for your attention to this matter.
Sincerely,
/s/
Thomas Hemingway
Show Raw Text
CORRESP
1
filename1.htm
August 19,
2024
Lauren
Hamill, Staff Attorney
Division
of Corporation Finance
Office
of Life Sciences
U.S.
Securities and Exchange Commission
100
F Street, NE
Washington,
D.C. 20549
Re:
Bioquest
Corp.
Offering
Statement on Form 1-A, as amended
Initially
Filed May 15, 2024
File
No. 024-12436
Dear
Ms. Hamill:
This
letter sets forth the request of BioQuest Corp., (“BQST” or the “Company”) for Qualification of its Regulation
A Offering on Form 1-A, as amended.
Kindly
be advised that BioQuest Corp. (the “Company”) requests that its Regulation A Offering, as amended, be qualified on Wednesday,
August 21, 2024 at 3pm (est) or as soon as practical thereafter. The Company confirms that the State of Georgia is prepared to qualify
the Offering.
In
connection with the foregoing request, the Company hereby confirms and acknowledges that:
1.
should
the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission from
taking any action with respect to the filing;
2.
the
action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve the Company
from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3.
the
Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United States.
We
trust the foregoing is in order.
If
you have any questions or require any additional information with respect to the above, please do not hesitate to contact me at (714)
978-4425. Thank you for your attention to this matter.
Sincerely,
/s/
Thomas Hemingway
CEO
and Director